The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study
Pharmacoepidemiology and drug safety | 18 Nov 2017
MF Daley, CL Clarke, JM Glanz, S Xu, SJ Hambidge, JG Donahue, JD Nordin, NP Klein, SJ Jacobsen, AL Naleway, ML Jackson, G Lee, J Duffy and E Weintraub
To evaluate the safety of live attenuated influenza vaccine (LAIV) in children 2 through 17 years of age.
* Data courtesy of Altmetric.com